About Wellinks
Wellinks is a digital healthcare company founded in 2012 and headquartered in New Haven, Connecticut, that specializes in chronic obstructive pulmonary disease (COPD) management and cardiopulmonary care. The company partners with health plans, providers, and value-based care organizations to deliver comprehensive virtual pulmonary care programs that bridge the gap between patients and healthcare providers. Wellinks' solution combines the Spire RPM (Remote Patient Monitoring) System with virtual pulmonary rehabilitation, one-on-one clinical coaching, 24/7 nurse triage, and personalized care management. The company recently acquired Spire Health, integrating cutting-edge patient monitoring technology to pioneer what they call "Predictive Patient Care." The Spire Tag is a lightweight wearable sensor that continuously tracks respiratory rate, heart rate, and activity levels, enabling early detection of exacerbations and proactive intervention. The company's clinical team includes certified health coaches, asthma educators, physicians, registered nurses, respiratory therapists, and clinical exercise physiologists who partner with patients to create evidence-based care plans. Wellinks addresses a critical gap in healthcare access: less than 4% of eligible COPD patients have access to pulmonary rehabilitation. Their virtual-first approach makes comprehensive respiratory care accessible and convenient, with appointments available in as little as two days. Wellinks serves multiple customer segments including Medicare Advantage plans, health insurers, health systems, risk-bearing entities, and primary care practices. The company has demonstrated significant clinical and economic outcomes, with research showing 45% fewer COPD-related ER visits, 65% reduction in hospitalizations, and average annual savings of $11,300 per patient. Wellinks operates primarily in the United States, with recent partnerships expanding their presence in New Jersey and Florida.
Mission & Story
Mission
Wellinks is dedicated to revolutionizing chronic cardiopulmonary care management through innovative solutions and patient-centered approaches.
Founding Story
Founded in 2012, Wellinks has a rich history of innovation in cardiopulmonary care, pioneering the development of a portable, connected nebulizer and now spearheading advancements in Predictive Patient Care using Spire technology.
Clinical Focus
Medical conditions and clinical areas addressed by Wellinks.
Who It Serves
Milestones & Awards
Recent Milestones
Acquired Spire Health to integrate cutting-edge patient monitoring technology (2024-2025). Partnership with CareAbout Health announced March 2025 to expand into New Jersey and Florida markets serving over one million patients. Collaboration with SoNE HEALTH launched September 2024. Showcased Spire Tag technology at ATS 2025 International Conference in San Francisco.
Key Partnerships
-min.avif)
.avif){kind=logo}
Company Details
- Founded
- 2012
- Headquarters
- New Haven, CT, USA
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 46 →
Abbott Diabetes Care
Abbott Diabetes Care develops FreeStyle Libre, a world-leading continuous glucose monitoring (CGM) portfolio for diabetes management with advanced analytics and innovation.
Amalgam Rx
Amalgam Rx develops AI-powered digital therapeutics and Software as a Medical Device (SaMD) solutions for chronic disease management. The company partners with life sciences companies, health plans, and providers to deliver regulated digital health applications and EHR-integrated clinical decision support tools.
Arkray
ARKRAY USA manufactures and distributes blood glucose monitoring systems, clinical diagnostic equipment, and oral wellness products. The company serves consumers with diabetes, healthcare professionals, and clinical laboratories with accurate, affordable diagnostic solutions.
BeatO
BeatO is a digital health platform specializing in diabetes management and weight loss solutions. The company offers smart glucose monitoring devices, GLP-1 weight loss programs, and a comprehensive diabetes care program combining connected devices, doctor consultations, and health coaching for over 2 million patients across India.
Brook Health
AI-powered remote patient monitoring and chronic disease management platform for conditions like diabetes, hypertension, and heart disease.
Cadence
Cadence delivers AI-powered remote patient care programs for chronic disease management. The company partners with health systems, payers, and medical groups to provide 24/7 monitoring, medication management, and clinical support for patients with hypertension, heart failure, diabetes, and other chronic conditions.
Cala Health
Cala Health develops the Cala kIQ System, an FDA-cleared wearable device that delivers non-invasive neuromodulation therapy for action hand tremor. The device uses transcutaneous afferent patterned stimulation (TAPS) to provide on-demand tremor relief for people with essential tremor and Parkinson's disease.
Calibrate
Calibrate is a metabolic health company that combines clinician-prescribed GLP-1 medications with 1:1 video coaching and science-backed curriculum to help members achieve sustainable weight loss. Members lose an average of 19% of their body weight achieved over three years.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.